Staar Surgical TICL
This article was originally published in The Gray Sheet
Executive Summary
Receipt of CE mark for toric implantable contact lens EU sales makes Staar's TICL the first posterior phakic intraocular lens able to reduce pre-existing astigmatism alongside myopia or hyperopia correction, the company says Dec. 3. The Monrovia, Calif. firm gained conditional IDE clearance in January for a 125-patient U.S. trial investigating the TICL to treat myopia of -3.0 to 20 diopters - and astigmatism of 1.0 to 4.0 D (1"The Gray Sheet" Jan. 14, 2002, In Brief). Staar implanted the first device in a U.S. patient's eye in August, with "excellent results [and] no surprises"...